LXRX
Lexicon Pharmaceuticals Inc
1.90$
+5.8%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Lexicon Pharmaceuticals Inc (LXRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -68 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -76 | 185 | -176 | -185 | -149 | 114 | -143 | -87 | -89 | -162 | -179 | -68 | |
| 1.9 | 0.7 | 2.1 | 3.4 | 3.7 | 3.7 | 2.9 | 0.3 | 0.4 | 0.6 | 0.5 | 0.6 | |
| 7.1 | 6.8 | 7.5 | 9.5 | 12 | 14 | 13 | 11 | 12 | 14 | 13 | 13 | |
| 20 | 16 | 6.8 | -1.1 | 12 | 8.2 | 13 | 11 | 12 | – | – | – | |
| 2.3 | 172 | -44 | -59 | -45 | -58 | 31 | -10 | 0.4 | 2.7 | 14 | -27 | |
| 0.1 | 0.9 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 1.2 | 1.3 | 0.5 | 1.0 | 0.0 | |
| -108 | -117 | 18 | 51 | 170 | -156 | 381 | 2.1 | -71 | -50 | -15 | 113 | |
| 0.0 | 0.0 | 2.0 | 0.0 | – | – | 217 | 12 | – | 100 | – | – | |
| -0.9 | -0.4 | -0.6 | -1.7 | -1.0 | -0.9 | -1.0 | -2.7 | -0.9 | -0.8 | -1.7 | -0.6 | |
| 82 | -1.9 | -2.0 | 144 | -2.0 | -1.3 | -217 | -12 | 49 | 50 | 0.0 | -48 | |
| 284 | -2.0 | 1.0 | 150 | -2.2 | -2.2 | -148 | 23 | 142 | 188 | 238 | -48 | |
| 100 | 66 | -156 | 15 | 19 | -44 | 90 | -62 | -18 | -24 | 44 | -3.3 | |
| -76 | 184 | -176 | -186 | -149 | 114 | -143 | -88 | -90 | -162 | -180 | -68 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.